DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in INVA — Innoviva, Inc.
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,791,428
+$6,860,178 QoQ
Shares Held
892,336
+28.0% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $379,217,691 across 26 Biotechnology names. INVA ranks #4 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
364,513 | $162,769,634 | |
| 2 | BNTX |
BioNTech SE
|
387,214 | $34,415,577 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,270 | $29,568,932 | |
| 4 | INVA |
Innoviva, Inc.
This page
|
892,336 | $20,791,428 | |
| 5 | INCY |
Incyte Corp
|
183,834 | $17,302,454 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
567,115 | $15,884,891 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
213,363 | $14,536,421 | |
| 8 | EXEL |
Exelixis, Inc.
|
334,487 | $14,346,147 |
All Filings in INVA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,791,428 | 892,336 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,931,250 | 696,911 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,221,570 | 450,497 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $136,612 | 6,800 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $318,979 | 17,594 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $503,150 | 29,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $679,712 | 35,200 | Shares | Defined | 2026-05-04 | |
| 2024-06-30 | $101,680 | 6,200 | Shares | Defined | 2026-05-04 | |
| 2024-03-31 | $94,488 | 6,200 | Shares | Defined | 2026-05-04 | |
| 2023-12-31 | $162,004 | 10,100 | Shares | Defined | 2026-05-04 | |
| 2023-09-30 | $1,947,837 | 149,949 | Shares | Defined | 2026-05-04 | |
| 2023-06-30 | $3,848,368 | 302,307 | Shares | Defined | 2026-05-04 | |
| 2023-03-31 | $3,034,980 | 269,776 | Shares | Defined | 2024-05-17 | |
| 2022-12-31 | $2,887,360 | 217,914 | Shares | Defined | 2024-05-17 | |
| 2022-09-30 | $5,535,148 | 476,757 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,480,702 | 439,072 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,646,388 | 291,803 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||